Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 924-751-7 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2022
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442E (In Vitro Skin Sensitisation assays addressing the key event on activation of dendritic cells on the Adverse Outcome Pathway for skin sensitisation)
- Version / remarks:
- 30 June 2022
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline No. 497: Defined Approaches for Skin Sensitisation - Annex I. Prediction model for the individual in chemico/in vitro tests with multiple runs for use in 2o3 DA
- Version / remarks:
- 14 June 2021
- GLP compliance:
- yes
- Type of study:
- human Cell Line Activation Test (h-CLAT)
- Details of test system:
- THP-1 cell line [442E]
- Vehicle / solvent control:
- DMSO
- Negative control:
- other: DMSO
- Positive control:
- dinitrochlorobenzene (DNCB) [442E]
- Key result
- Group:
- test chemical
- Run / experiment:
- run/experiment 1
- Parameter:
- CV70 [442E]
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- not determinable
- Remarks:
- Since no cytotoxicity was observed either no CV75 value was calculated
- Outcome of the prediction model:
- negative [in vitro/in chemico]
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based on these results, the OECD 442E and OECD 497 prediction models, the test item “Ozonia 3000 Sunflower (Ozonized Sunflower Seed Oil)” was shown to be negative and demonstrated in vitro non-sensitising potential under the experimental conditions of the human Cell Line activation Test.
- Executive summary:
In the course of this study the skin sensitisation potential of “Ozonia 3000 Sunflower (Ozonized Sunflower Seed Oil)” was examined.
The extent of cytotoxicity induced on THP-1 cells by the test item was studied in two runs of the dose finding test. The maximal final concentrations used on the plates for the test item previously dissolved in DMSO were 1000.0 μg/mL (first run) and 1001.0 μg/mL (second run). Since no cytotoxicity was observed in the first run, the same concentration range was used in the second run and start from the highest allowed concentration (1000 μg/mL). Since in the second run no cytotoxicity was observed either, no CV75 value was calculated. Based on the results of two runs of the dose finding test, eight doses between 1000.0 μg/mL – 279.1 μg/mL (nominal concentrations) were used for the main test in two independent runs. Both runs were concluded valid.
The increase in CD86 marker expression (RFI) was lower than 150 % at all tested doses (with > 50 % of cell viability) compared to the respective negative controls in both valid runs. Moreover, according to the OECD Test Guideline 497 prediction model, the increase in CD86 marker expression (RFI) was below the borderline range (122-184 %) at all tested concentrations compared to the respective negative controls in all independent runs. Also, no cytotoxicity was observed at any tested concentrations in either independent run. Based on the two valid concordant negative runs, CD86 marker expression was concluded to be negative. Effective concentration for CD86 expression (EC150) was not determined, since a negative result was obtained.
The increase in CD54 marker expression (RFI) was lower than 200 % at all tested concentrations compared to the respective negative controls in both independent valid runs. Moreover, according to the OECD Test Guideline 497 prediction model, the increase in CD54 marker expression (RFI) was below the borderline range (157-255 %) at all tested concentrations compared to the respective negative controls in both independent runs. Furthermore, no cytotoxicity was observed at any tested concentrations in either independent run.
Based on the two valid concordant negative runs, CD54 marker expression was concluded to be negative. Effective concentration for CD54 expression (EC200) was not determined, since a negative result was obtained.
Since both CD86 and CD54 marker expressions gave negative results, the overall h-CLAT prediction was also concluded to be negative.
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 2022
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 luciferase KeratinoSens™ test method)
- Version / remarks:
- 30 June 2022
- Qualifier:
- according to guideline
- Guideline:
- other: OECD Guideline No. 497: Defined Approaches for Skin Sensitisation - Annex I. Prediction model for the individual in chemico/in vitro tests with multiple runs for use in 2o3 DA
- Version / remarks:
- 14 June 2021
- GLP compliance:
- yes
- Type of study:
- ARE-Nrf2 luciferase KeratinoSens™ test method
- Details of test system:
- Keratinoses transgenic cell line [442D]
- Vehicle / solvent control:
- DMSO
- Negative control:
- other: DMSO
- Positive control:
- cinnamic aldehyde [442D]
- Positive control results:
- The positive control used was Trans-Cinnamaldehyde for which a series of five 100 × master concentrations ranging from 0.4 to 6.4 mM were prepared in DMSO (from a 200 mM stock solution) and diluted as described for the 4 × master solutions. The final concentration of the positive control on the treated plates ranged from 4 to 64 μM.
- Key result
- Group:
- test chemical
- Run / experiment:
- run/experiment 1
- Parameter:
- EC 1.5 [442D]
- Value:
- 220.25 µg/mL
- Cell viability:
- yes (≥70%)
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- no indication of skin sensitisation
- Group:
- test chemical
- Run / experiment:
- run/experiment 2
- Parameter:
- IC50 [442D]
- Cell viability:
- no (<70%)
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- not determinable
- Remarks:
- The test item induced no cytotoxicity (or viability below 70 %) compared to the solvent/vehicle control at any concentrations in KeratinoSens™ cells. Thus, IC30 and IC50 values were not calculated.
- Group:
- test chemical
- Run / experiment:
- run/experiment 3
- Parameter:
- EC 1.5 [442D]
- Cell viability:
- no (<70%)
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- not determinable
- Remarks:
- The test item induced no cytotoxicity (or viability below 70 %) compared to the solvent/vehicle control at any concentrations in KeratinoSens™ cells. Thus, IC30 and IC50 values were not calculated.
- Outcome of the prediction model:
- negative [in vitro/in chemico]
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- Based on these results and prediction models of OECD 442D and OECD 497, the test item “Ozonia 3000 Sunflower (Ozonized Sunflower Seed Oil)” is concluded borderline for skin sensitisation potential (between skin sensitization and non-skin sensitization) under the experimental conditions of KeratinoSens™ method (ARE-Nrf2 Luciferase Test Method).
- Executive summary:
In the course of this study the skin sensitisation potential of the test item “Ozonia 3000 Sunflower (Ozonized Sunflower Seed Oil)” was studied using the KeratinoSens™ method (ARE-Nrf2 Luciferase Test Method). In order to derive a prediction for the test item the results of three independent tests were used. Since the results of the two tests were not concordant, a third was needed in order to derive a conclusion. The luciferase activity induction obtained with the positive control, Trans-Cinnamaldehyde, was dose-dependent and statistically significant above the threshold of 1.5-fold in all tests. Since no defined molecular weight is available for the test item, 40 mg/mL final concentration of the test item was used in the study instead of 200 mM in accordance with the test guideline. For the test item, twelve doses ranging from 400.00 μg/mL to 0.20 μg/mL were used in all valid tests. The test item induced no cytotoxicity (a substance is considered cytotoxic if the viability is below 70 %) in KeratinoSens™ cells compared to the solvent/vehicle control. Thus, in none of the tests IC30 or IC50 values could be determined. The induction values of the test item did not exceed the 1.5-fold threshold at any tested concentrations compared to the respective negative control in the second and third tests. In the first test, there was only one induction value of the test item which exceeded the 1.5-fold threshold compared to the respective negative control at the highest tested concentration (400.00 μg/mL). Moreover, according to the OECD Test Guideline 497 prediction model, there were one or two concentrations per tests where the induction values of the test item were within or above the borderline threshold range (1.35-1.67-fold) compared to the respective negative control in all three valid tests. Because of the obtained results and based on the predictions models, the test item was concluded borderline. The EC1.5 value was determined for the first test only and it was calculated as 220.25 μg/mL. Furthermore, the overall Imax value was determined as 1.65-fold. In addition, a clear dose response could be observed throughout the study.
Referenceopen allclose all
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
Justification for classification or non-classification
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.